One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   High Throughput Screening Market

ハイスループットスクリーニング。市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2023年


[ 英語タイトル ] High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023


Product Code : MNMHC00109707
Survey : MarketsandMarkets
Publish On : May, 2021
Number of Pages : 245
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global high-throughput screening (HTS) market projected to grow at a CAGR of 7.8%.”
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.

“The software segment is expected to register the highest CAGR during the forecast period.”
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.

“Contract research organizations are expected to grow at the fastest rate during the forecast period.”
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.

“APAC is projected to witness the highest growth during the forecast period.”
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–31%, Tier 2–46% and Tier 3–23%
• By Designation – C-level–42%, Director Level–26%, Others–32%
• By Region – North America–35%, Europe–30%, Asia Pacific–21%, RoW–14%

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
Research Coverage:
The report analyzes the various HTS products and their adoption pattern. It aims at estimating the market size and future growth potential of the global HTS market for different segments such as product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global HTS market
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global HTS market
• Market Development: Comprehensive information on the lucrative emerging regions by product & service, technology, application, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global HTS market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global HTS market

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 SCOPE OF THE STUDY 23
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED IN THE REPORT 24
1.4 CURRENCY 24
1.5 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH APPROACH 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 27
2.1.2.1 Key data from primary sources 28
2.1.2.2 Key industry insights 29
2.2 MARKET SIZE ESTIMATION 30
2.2.1 BOTTOM-UP APPROACH 30
2.2.2 TOP-DOWN APPROACH 31
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.4 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 37
4.1 HIGH-THROUGHPUT SCREENING: MARKET OVERVIEW 37
4.2 HTS MARKET: DEVELOPED VS DEVELOPING COUNTRIES (2018 VS 2023) 37
4.3 GEOGRAPHIC SNAPSHOT: HTS MARKET (2017) 38
4.4 GEOGRAPHIC MIX: HTS MARKET 39
4.5 HTS MARKET, BY PRODUCT & SERVICES (2018 VS 2023) 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 MARKET DRIVERS 41
5.2.1.1 Growing adoption of open innovation models in pharmaceutical and biotechnology companies 41

5.2.1.2 Government funding and venture capital investments 41
5.2.1.3 Increasing R&D spending 42
5.2.1.4 Technological advancements 43
5.2.2 MARKET RESTRAINTS 44
5.2.2.1 Capital-intensive nature of HTS 44
5.2.2.2 Complexities in the field of assay development 44
5.2.3 MARKET OPPORTUNITIES 45
5.2.3.1 Emerging markets 45
5.2.3.2 Growing research activities in toxicology and stem cells 45
5.2.4 MARKET CHALLENGES 46
5.2.4.1 Dearth of skilled operators 46
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 TECHNOLOGICAL TRENDS 47
6.2.1 LABEL-FREE TECHNOLOGY 47
6.2.2 AUTOMATION & MINIATURIZATION 47
6.2.3 MICROFLUIDICS 48
6.3 HTS IN DRUG DISCOVERY PROCESS 48
7 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE 50
7.1 INTRODUCTION 51
7.2 REAGENTS & ASSAY KITS 52
7.3 INSTRUMENTS 53
7.4 CONSUMABLES & ACCESSORIES 55
7.5 SOFTWARE 56
7.6 SERVICES 57
8 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY 58
8.1 INTRODUCTION 59
8.2 CELL-BASED ASSAYS 60
8.2.1 2D CELL CULTURE 61
8.2.2 3D CELL CULTURE 62
8.2.2.1 Scaffold-based technology 64
8.2.2.1.1 Hydrogels 65
8.2.2.1.1.1 Animal-derived hydrogels 67
8.2.2.1.1.1.1 Matrigel 68
8.2.2.1.1.1.2 Collagen 69
8.2.2.1.1.2 Synthetic hydrogels 70
8.2.2.1.1.3 Alginate/Agarose 71

8.2.2.1.2 Inert matrix/Solid scaffolds 72
8.2.2.1.3 Micropatterned surfaces 73
8.2.2.2 Scaffold-free technology 74
8.2.2.2.1 Microplates 76
8.2.2.2.2 Hanging-drop plates 77
8.2.2.2.3 Ultra-low binding plates 78
8.2.2.2.4 Other scaffold-free technologies 79
8.2.3 PERFUSION CELL CULTURE 80
8.3 LAB-ON-A-CHIP 82
8.4 ULTRA-HIGH-THROUGHPUT SCREENING 83
8.5 BIOINFORMATICS 84
8.6 LABEL-FREE TECHNOLOGY 85
9 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION 87
9.1 INTRODUCTION 88
9.2 TARGET IDENTIFICATION AND VALIDATION 89
9.3 PRIMARY AND SECONDARY SCREENING 90
9.4 TOXICOLOGY ASSESSMENT 91
9.5 OTHER APPLICATIONS 93
10 HIGH-THROUGHPUT SCREENING MARKET, BY END USER 94
10.1 INTRODUCTION 95
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 96
10.3 ACADEMIC AND GOVERNMENT INSTITUTES 97
10.4 CONTRACT RESEARCH ORGANIZATIONS (CRO) 98
10.5 OTHER END USERS 99
11 HIGH-THROUGHPUT SCREENING MARKET, BY REGION 101
11.1 INTRODUCTION 102
11.2 NORTH AMERICA 103
11.2.1 US 109
11.2.2 CANADA 114
11.3 EUROPE 119
11.3.1 GERMANY 124
11.3.2 UK 128
11.3.3 FRANCE 133
11.3.4 ITALY 137
11.3.5 SPAIN 142
11.3.6 REST OF EUROPE 147

11.4 ASIA PACIFIC 152
11.4.1 JAPAN 157
11.4.2 CHINA 162
11.4.3 INDIA 166
11.4.4 REST OF ASIA PACIFIC 171
11.5 LATIN AMERICA 175
11.6 MIDDLE EAST AND AFRICA 180
12 COMPETITIVE LANDSCAPE 185
12.1 INTRODUCTION 185
12.2 MARKET LEADERSHIP ANALYSIS 186
12.3 COMPETITIVE SCENARIO 186
12.3.1 PRODUCT LAUNCHES AND UPGRADES 187
12.3.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 187
12.3.3 EXPANSIONS 188
12.3.4 ACQUISITIONS 188
12.3.5 OTHER DEVELOPMENTS 189
13 COMPANY PROFILES 190
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 THERMO FISHER SCIENTIFIC INC. 190
13.2 AGILENT TECHNOLOGIES, INC. 195
13.3 DANAHER CORPORATION 201
13.4 PERKINELMER, INC. 205
13.5 TECAN GROUP 210
13.6 AXXAM S.P.A. 214
13.7 BIO-RAD LABORATORIES 218
13.8 MERCK GROUP 221
13.9 HAMILTON COMPANY 225
13.10 CORNING INCORPORATED 228
13.11 BIOTEK INSTRUMENTS 230
13.12 AURORA BIOMED 233
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 234
14.1 DISCUSSION GUIDE 234
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 239
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 241
14.4 AVAILABLE CUSTOMIZATIONS 243
14.5 RELATED REPORTS 243
14.6 AUTHOR DETAILS 244

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+